Trial Profile
Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Diabetes mellitus; Hyperlipidaemia; Hypertension; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms METATEL
- 29 Aug 2011 Results published in the Hypertension.
- 14 Jul 2010 Actual number of patients (56) added as reported by ClinicalTrials.gov.
- 12 Jul 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.